IDH2 and acute myeloid leukemia: IDH1 and IDH2, which catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle, are mutated in AML with reported incidence of ~20% [114].